-Advertisement-
-Advertisement-
Neurology
CereVasc announces positive trial results for new NPH treatment
CereVasc, Inc has announced promising initial results from its pilot clinical study evaluating the eShunt System for treating elderly patients with normal-pressure hydrocephalus (NPH), according to a company press release. The study included 30 patients and achieved its primary safety and efficacy endpoints. No serious adverse events related to the...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
Contact
© 2025 Med Journal 360® is a trademark of International Healthcare Media, LLC. All rights Reserved